Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Fanny, Foubert"'
Autor:
Tamara Matysiak-Budnik, Hélène Senellart, Paul Girot, Marie-Françoise Heymann, Aurélien Venara, Clotilde Dumars, Yann Touchefeu, Fanny Foubert, Nicolas Regenet, Maëva Salimon
Publikováno v:
Journal of Gastrointestinal Oncology. 10:103-111
BACKGROUND: Intestinal and pancreatic neuroendocrine tumors (IP-NETs) are rare tumors with heterogeneous outcomes. The aim of our study was to determine the clinical, therapeutic and pathological factors which impact the overall survival (OS) in IP-N
Autor:
Tamara Matysiak-Budnik, Yann Touchefeu, Clotilde Dumars, Fanny Foubert, Marie-Françoise Heymann, Hélène Senellart, Nicolas Regenet
Publikováno v:
Endocrine
Endocrine, 2016, 53, pp.395-401. ⟨10.1007/s12020-016-0944-3⟩
Endocrine, Springer, 2016, 53, pp.395-401. ⟨10.1007/s12020-016-0944-3⟩
Endocrine, 2016, 53, pp.395-401. ⟨10.1007/s12020-016-0944-3⟩
Endocrine, Springer, 2016, 53, pp.395-401. ⟨10.1007/s12020-016-0944-3⟩
International audience; Therapeutic strategy in neuroendocrine tumors (NETs) is based on histological characteristics of the primary tumor (PT), even in case of metastatic disease. Our aim was to compare the tumor grade between PT and their liver met
Autor:
Fanny, Foubert, Sébastien, Gouard, Catherine, Saï-Maurel, Michel, Chérel, Alain, Faivre-Chauvet, David M, Goldenberg, Jacques, Barbet, Clément, Bailly, Caroline, Bodet-Milin, Thomas, Carlier, Françoise, Kraeber-Bodéré, Yann, Touchefeu, Eric, Frampas
Publikováno v:
Oncotarget. 9(44)
The aim of this study was to compare the performances pretargeted immunoPETHepatic tumor burden following intra-portal injection of luciferase-transfected LS174T cells in nude mice was confirmed using bioluminescence. One group of animals was injecte
Autor:
Caroline Eymerit-Morin, Marie-Christine Rousselet, Dominique Luet, Lionel Fizanne, Carole Vitellius, Fanny Foubert, François-Xavier Caroli-Bosc, Sandrine Bertrais
Publikováno v:
Clinical Drug Investigation
Clinical Drug Investigation, Springer Verlag, 2017, 37 (7), pp.669-677. ⟨10.1007/s40261-017-0522-3⟩
Clinical Drug Investigation, Springer Verlag, 2017, 37 (7), pp.669-677. ⟨10.1007/s40261-017-0522-3⟩
International audience; BACKGROUND: To date, no predictive biomarker for the efficacy of FOLFIRINOX in metastatic pancreatic adenocarcinoma has been demonstrated. Deficiency in O6-methylguanine-DNA methyltransferase (MGMT) has been associated with a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc07cc4bc71b460552723a9b719b9f58
https://hal.univ-angers.fr/hal-02448844
https://hal.univ-angers.fr/hal-02448844
Autor:
Carole, Vitellius, Caroline, Eymerit-Morin, Dominique, Luet, Lionel, Fizanne, Fanny, Foubert, Sandrine, Bertrais, Marie-Christine, Rousselet, François-Xavier, Caroli-Bosc
Publikováno v:
Clinical drug investigation. 37(7)
To date, no predictive biomarker for the efficacy of FOLFIRINOX in metastatic pancreatic adenocarcinoma has been demonstrated. Deficiency in OThe aim of our study was to assess the prevalence of MGMT and p53 in patients with metastatic pancreatic ade
Autor:
Fanny Foubert, Hélène Senellart, Nicolas Regenet, Estelle Cauchin, François-Xavier Caroli-Bosc, Léa Muzellec, Yann Touchefeu, Paul Girot, Clotilde Dumars, Jean-François Mosnier, Tamara Matysiak-Budnik
Publikováno v:
European Journal of Gastroenterology & Hepatology
European Journal of Gastroenterology & Hepatology, 2017, 29 (7), pp.826-830. ⟨10.1097/MEG.0000000000000874⟩
European Journal of Gastroenterology & Hepatology, 2017, 29 (7), pp.826-830. ⟨10.1097/MEG.0000000000000874⟩
International audience; OBJECTIVE: Temozolomide (TMZ) is an alkylating agent frequently used in well-differentiated metastatic pancreatic neuroendocrine tumors (PNETs) with very variable responses. O-methylguanine-DNA methyltransferase (MGMT) is a DN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ba473b07503360e05ac5647c8bdddb9
https://hal.univ-angers.fr/hal-02648813
https://hal.univ-angers.fr/hal-02648813
Publikováno v:
Digestive and Liver Disease. 46:105-112
Colorectal cancer is the third most common cancer, with recent advances in the management of unresectable metastatic lesions. The aim of this review is to discuss the remaining options for heavily pretreated patients with unresectable metastatic colo
Autor:
Alain Faivre-Chauvet, Fanny Foubert, Michel Chérel, Eric Frampas, Catherine Maurel, Sébastien Gouard, Yann Touchefeu
Publikováno v:
Journal of Clinical Oncology. 33:e22128-e22128
e22128 Background: The aim of our study was to compare the performances of a pretargeted PET (pPET) imaging with anti-CEA (carcinoembryonic antigen) and anti-HSG (histamine-succinyl-glycine) recomb...
Autor:
Yann Touchefeu, Fanny Foubert, Clotilde Dumars, Marie-Françoise Heymann, Nicolas Regenet, Hélène Senellart, Tamara Matysiak-Budnik
Publikováno v:
Gastroenterology. 148:S-934
Autor:
Yann Touchefeu, Fanny Foubert, Sébastien Gouard, Michel Chérel, Catherine Maurel, Eric Frampas, Alain Faivre-Chauvet
Publikováno v:
Gastroenterology. 148:S-230